Ignite Creation Date:
2024-05-05 @ 5:29 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00464789
Status:
COMPLETED
Last Update Posted:
2007-12-28
First Post:
2007-04-23
Brief Title:
Study Evaluating BazedoxifeneConjugated Estrogens Combinations In Healthy Postmenopausal Women
Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization:
Wyeth is now a wholly owned subsidiary of Pfizer
Study Overview
Official Title:
An Open-Label Single-Dose Randomized 3-Period Crossover Bioequivalence Study Between BazedoxifeneConjugated Estrogens Premarin Current Process And BazedoxifeneConjugated Estrogens Premarin New Process In Healthy Postmenopausal Women
Status:
COMPLETED
Status Verified Date:
2007-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
BazedoxifeneConjugated Estrogens BZACE is an investigational drug that is being developed for treatment of menopause The purpose of this trial is to compare a new manufacturing process for making BZACE to the current process by assessing the way it is absorbed into the blood
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None